O-Benzoylthiamine disulfide （BTDs）， Bestonの眼科領域における使用経験と大量療法について

Study for the effect of massive therapy on various eye diseases with o-Benzoyl-thiamine disulfide (BTDS), "Beston"

I．はじめに

　最近，持続型活性ビタミンB₁剤の大量療法が問題になりつつある。

　持続型活性ビタミンB₁剤は，従来のビタミンB₁剤に比して，次のような特徴を有している。

Massive doses (100~600 mg) of o-Benzoyl-thiamine disulfide (BTDS), "Beston" were administered to 72 cases with various eye diseases during the seven months from June to December, 1963.

The results were as follows.

1) The period of treatment could be dis-tinctly shortened in such diseases that gene-rally follow a chronic course, as central retinitis, chronic axial neuritis, acute retrobu-lbar neuritis, bulbar conjunctivitis, episcleritis and scleritis.